Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy.

Pan JW, Coyle PK, Bashir K, Whitaker JN, Krupp LB, Hetherington HP.

Mult Scler. 2002 May;8(3):200-6.

PMID:
12120690
[PubMed - indexed for MEDLINE]
2.

[Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].

Pozdniakov AV, Tiutin LA, Bisaga GN, Odinak MM.

Zh Nevrol Psikhiatr Im S S Korsakova. 2001;101(4):36-9. Russian.

PMID:
11490432
[PubMed - indexed for MEDLINE]
3.

(1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.

Sijens PE, Mostert JP, Oudkerk M, De Keyser J.

Eur Radiol. 2006 Feb;16(2):489-95. Epub 2005 Jul 19.

PMID:
16028056
[PubMed - indexed for MEDLINE]
4.

Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.

Adalsteinsson E, Langer-Gould A, Homer RJ, Rao A, Sullivan EV, Lima CA, Pfefferbaum A, Atlas SW.

AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1941-5.

PMID:
14625214
[PubMed - indexed for MEDLINE]
Free Article
5.

Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis.

Cucurella MG, Rovira A, Río J, Pedraza S, Tintoré MM, Montalbán X, Alonso J.

NMR Biomed. 2000 Apr;13(2):57-63.

PMID:
10797633
[PubMed - indexed for MEDLINE]
6.

Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.

Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.

Arch Neurol. 2007 Aug;64(8):1163-8.

PMID:
17698707
[PubMed - indexed for MEDLINE]
7.

Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis.

Oguz KK, Kurne A, Aksu AO, Karabulut E, Serdaroglu A, Teber S, Haspolat S, Senbil N, Kurul S, Anlar B.

AJNR Am J Neuroradiol. 2009 Apr;30(4):716-21. doi: 10.3174/ajnr.A1425. Epub 2009 Jan 15.

PMID:
19147724
[PubMed - indexed for MEDLINE]
Free Article
8.

(1)H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis.

Caramanos Z, DiMaio S, Narayanan S, Lapierre Y, Arnold DL.

J Neurol Sci. 2009 Jul 15;282(1-2):72-9. doi: 10.1016/j.jns.2009.01.015. Epub 2009 Feb 20.

PMID:
19232641
[PubMed - indexed for MEDLINE]
9.

Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study.

Mader I, Roser W, Kappos L, Hagberg G, Seelig J, Radue EW, Steinbrich W.

AJNR Am J Neuroradiol. 2000 Aug;21(7):1220-7.

PMID:
10954272
[PubMed - indexed for MEDLINE]
Free Article
10.

Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis.

Li BS, Regal J, Soher BJ, Mannon LJ, Grossman RI, Gonen O.

AJNR Am J Neuroradiol. 2003 Jan;24(1):68-74.

PMID:
12533329
[PubMed - indexed for MEDLINE]
Free Article
11.

Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T.

Pan JW, Hetherington HP, Vaughan JT, Mitchell G, Pohost GM, Whitaker JN.

Magn Reson Med. 1996 Jul;36(1):72-7.

PMID:
8795023
[PubMed - indexed for MEDLINE]
12.

Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-beta therapy on absolute metabolite concentrations.

Schubert F, Seifert F, Elster C, Link A, Walzel M, Mientus S, Haas J, Rinneberg H.

MAGMA. 2002 Jun;14(3):213-22.

PMID:
12098564
[PubMed - indexed for MEDLINE]
13.

1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.

Suhy J, Rooney WD, Goodkin DE, Capizzano AA, Soher BJ, Maudsley AA, Waubant E, Andersson PB, Weiner MW.

Mult Scler. 2000 Jun;6(3):148-55.

PMID:
10871825
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis.

Mathiesen HK, Tscherning T, Sorensen PS, Larsson HB, Rostrup E, Paulson OB, Hanson LG.

Magn Reson Med. 2005 Apr;53(4):750-9.

PMID:
15799064
[PubMed - indexed for MEDLINE]
15.

Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.

Tourbah A, Stievenart JL, Gout O, Fontaine B, Liblau R, Lubetzki C, Cabanis EA, Lyon-Caen O.

Neurology. 1999 Sep 22;53(5):1091-7.

PMID:
10496272
[PubMed - indexed for MEDLINE]
16.

Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.

Sarchielli P, Presciutti O, Pelliccioli GP, Tarducci R, Gobbi G, Chiarini P, Alberti A, Vicinanza F, Gallai V.

Brain. 1999 Mar;122 ( Pt 3):513-21.

PMID:
10094259
[PubMed - indexed for MEDLINE]
Free Article
17.

The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.

Abo-Krysha N, Rashed L.

Mult Scler. 2008 Jun;14(5):602-8. doi: 10.1177/1352458507085550. Epub 2008 Apr 11.

PMID:
18408021
[PubMed - indexed for MEDLINE]
18.

Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.

He J, Inglese M, Li BS, Babb JS, Grossman RI, Gonen O.

Radiology. 2005 Jan;234(1):211-7. Epub 2004 Nov 4.

PMID:
15528260
[PubMed - indexed for MEDLINE]
19.

Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.

Hannoun S, Bagory M, Durand-Dubief F, Ibarrola D, Comte JC, Confavreux C, Cotton F, Sappey-Marinier D.

PLoS One. 2012;7(3):e32525. doi: 10.1371/journal.pone.0032525. Epub 2012 Mar 30. Erratum in: PLoS One. 2012;7(8): doi/10.1371/annotation/beed29e2-e61a-4d2f-8baa-ac53cf2fee7b.

PMID:
22479330
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk